TI  - Folfiri Plus Panitumumab as the First-Line Treatment in Patients with KRAS Wild-Type Metastatic Colorectal Cancer. A Single Center Experience
AU  - Geredeli, Ç.
SO  - European Archives of Medical Research 2018;34:98-104.
DO  - 10.5222/otd.2018.70431